Sign In
NewsRadar

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.

   


NOXXON receives research grant from the Federal Ministry of Education and Research


Berlin, Germany April 7, 2008: NOXXON announced today that the company was awarded a research grant from Germany’s Federal Ministry of Education and Research (BMBF). NOXXON will receive approximately one million Euro in research funding under the BioChancePlus initiative, a program that supports innovative research in biotechnology companies. The program is dedicated to further strengthen and broaden NOXXON’s drug discovery platform to identify innovative medicines based on mirror-image oligonucleotides (Spiegelmers®). NOXXON’s Chief Scientific Officer Dr. Sven Klussmann commented: “We are delighted that the government has decided to reward NOXXON’s excellent research. The funding will be beneficial in supporting the development and growth of existing and new technologies.”

About NOXXON Pharma AG:
Based on one of the biggest and best protected patent portfolios in the industry, Berlin-based NOXXON Pharma AG develops biostable aptamers, novel substances based on mirror image nucleic acids. These so-called Spiegelmers® (the German word “Spiegel” means mirror) are highly specific for the pharmacologically relevant target for which they were selected. Thanks to their structural characteristics, Spiegelmers® are extremely resistant to degradation and not immunogenic - a new generation of improved therapeutics.


Website info:
http://www.noxxon.net

General contact:
Emmanuelle Delabre
NOXXON Pharma AG
Max-Dohrn-Strasse 8-10
10589 Berlin, Germany
Phone: + 49 30 72 62 47 0
FAX: + 49 30 72 62 47 225
Email: mailto:edelabre@noxxon.net


Publisher Contact Information:

Noxxon Pharma AG
+ 49 30 72 62 47 0
edelabre@noxxon.net

Company profile of Noxxon Pharma AG
Past press releases of Noxxon Pharma AG.

Data


25,747
Tech investments
From our Online Data Service
16,670
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
May 24€4.1MArtificial Intelligence
May 24€0.6MArtificial Intelligence
May 24€3.0MMedical devices
May 24€9.0MRobotics
May 23N/AConsumer applications
May 23€4.5MInternet services
May 23€12.0MOther Biotechnology & Healthcare

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


Apr 29
Nethone
nethone raised over $1 million from innovation nest

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

Jan 2
Urban Jungle
urban jungle raises £1m in seed funding to build tech-enabled home ...

Aug 17
Komed Health
komed health closes seed financing round





About usContact usLegal Information
Copyright © 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.